SHH and cholangiocarcinoma: In the context of chronic liver disease, Shh and its downstream transcription factor, Gli2, have been extensively implicated in a variety of processes including regeneration [17], epithelial-mesenchymal transitions [18, 19], remodeling / repair after biliary obstruction [20–22] and cholangiocarcinoma [23].